Search research articles
Contact Us
Filters
Showing results (31-40 of 128) with videos related to
Page
of 13
Sort By:
Psycho-Oncology
|
March 1, 2013
Conveying genomic recurrence risk estimates to patients with early-stage breast cancer: oncologist perspectives
Elizabeth Spellman, Nadiyah Sulayman, Susan Eggly, et al.
Breast Cancer Research and Treatment
|
October 27, 2006
Predictors and outcomes of contralateral prophylactic mastectomy among breast cancer survivors
Kristi D Graves, Beth N Peshkin, Chanita H Halbert, et al.
Pharmacogenomics
|
January 19, 2022
Evaluation of a longitudinal pharmacogenomics education on pharmacist knowledge in a multicampus healthcare system
Andrew J Lee, Adrian C Hui, Alexander D Walker, et al.
Healthcare (Basel, Switzerland)
|
July 16, 2016
Understanding the Needs of Young Women Regarding Breast Cancer Risk Assessment and Genetic Testing: Convergence and Divergence among Patient-Counselor Perceptions and the Promise of Peer Support
Chalanda Evans, Rebekah J Hamilton, Kenneth P Tercyak, et al.
Familial Cancer
|
November 11, 2017
Information and support needs of young women regarding breast cancer risk and genetic testing: adapting effective interventions for a novel population
Suzanne C O'Neill, Chalanda Evans, Rebekah J Hamilton, et al.
Journal of Genetic Counseling
|
February 22, 2008
Role of parenting relationship quality in communicating about maternal BRCA1/2 genetic test results with children
Tiffani A DeMarco, Beth N Peshkin, Heiddis B Valdimarsdottir, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 29, 2003
Bilateral prophylactic oophorectomy and ovarian cancer screening following BRCA1/BRCA2 mutation testing
Marc D Schwartz, Elizabeth Kaufman, Beth N Peshkin, et al.
Familial Cancer
|
March 3, 2011
BRCA1/2 genetic testing uptake and psychosocial outcomes in men
Kristi D Graves, Rhoda Gatammah, Beth N Peshkin, et al.
Journal of Cancer Epidemiology
|
August 18, 2012
Psychosocial and Quality of Life in Women Receiving the 21-Gene Recurrence Score Assay: The Impact of Decision Style in Women with Intermediate RS
Nadiyah Sulayman, Elizabeth Spellman, Kristi D Graves, et al.
Pharmacogenomics
|
November 9, 2023
Pharmacogenomic testing in oncology: a health system's approach to identify oncology provider perspectives
Meghna Bhatt, Beth N Peshkin, Sadaf Kazi, et al.
Page
of 13
Search research articles
Search
Showing results (31-40 of 128) with videos related to
Sort By:
Page
of 13
Psycho-Oncology
|
March 1, 2013
Conveying genomic recurrence risk estimates to patients with early-stage breast cancer: oncologist perspectives
Elizabeth Spellman, Nadiyah Sulayman, Susan Eggly, et al.
Breast Cancer Research and Treatment
|
October 27, 2006
Predictors and outcomes of contralateral prophylactic mastectomy among breast cancer survivors
Kristi D Graves, Beth N Peshkin, Chanita H Halbert, et al.
Pharmacogenomics
|
January 19, 2022
Evaluation of a longitudinal pharmacogenomics education on pharmacist knowledge in a multicampus healthcare system
Andrew J Lee, Adrian C Hui, Alexander D Walker, et al.
Healthcare (Basel, Switzerland)
|
July 16, 2016
Understanding the Needs of Young Women Regarding Breast Cancer Risk Assessment and Genetic Testing: Convergence and Divergence among Patient-Counselor Perceptions and the Promise of Peer Support
Chalanda Evans, Rebekah J Hamilton, Kenneth P Tercyak, et al.
Familial Cancer
|
November 11, 2017
Information and support needs of young women regarding breast cancer risk and genetic testing: adapting effective interventions for a novel population
Suzanne C O'Neill, Chalanda Evans, Rebekah J Hamilton, et al.
Journal of Genetic Counseling
|
February 22, 2008
Role of parenting relationship quality in communicating about maternal BRCA1/2 genetic test results with children
Tiffani A DeMarco, Beth N Peshkin, Heiddis B Valdimarsdottir, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 29, 2003
Bilateral prophylactic oophorectomy and ovarian cancer screening following BRCA1/BRCA2 mutation testing
Marc D Schwartz, Elizabeth Kaufman, Beth N Peshkin, et al.
Familial Cancer
|
March 3, 2011
BRCA1/2 genetic testing uptake and psychosocial outcomes in men
Kristi D Graves, Rhoda Gatammah, Beth N Peshkin, et al.
Journal of Cancer Epidemiology
|
August 18, 2012
Psychosocial and Quality of Life in Women Receiving the 21-Gene Recurrence Score Assay: The Impact of Decision Style in Women with Intermediate RS
Nadiyah Sulayman, Elizabeth Spellman, Kristi D Graves, et al.
Pharmacogenomics
|
November 9, 2023
Pharmacogenomic testing in oncology: a health system's approach to identify oncology provider perspectives
Meghna Bhatt, Beth N Peshkin, Sadaf Kazi, et al.
Page
of 13